Schering-Plough Ends Clarinex Fight With Orchid Over Patents

Schering-Plough has settled a patent lawsuit against Orchid Chemicals & Pharmaceuticals and Orgenus Pharma over their proposed generic versions of solid oral dosage formulations of the allergy drug Clarinex. The agreement will allow Chennai, India-based Orchid, which had alleged that the ’274 and ’223 patents covering the drug are invalid, to introduce a generic version of Clarinex (desloratadine) orally disintegrating tablets Jan. 1, 2012, and Clarinex 5-mg tablets July 1, 2012, Schering-Plough says in a statement. Orgenus is a U.S. subsidiary of Orchid.
Generic Line